Patents for C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027) |
---|
04/18/2002 | US20020045746 Form L crystalline eplerenone having a monoclinic crystal system and an X-ray powder diffraction pattern with a peak at 8. 0+-0.2 degrees 2 theta . |
04/11/2002 | US20020042507 Process for preparation of 9,11-epoxy steroids and intermediates useful therein |
03/28/2002 | US20020038021 Eplerenone crystalline form exhibiting enhanced dissolution rate |
03/14/2002 | US20020032340 Antitumor and antirheumatic agents, high binding afinity to vitamin D receptors and weak hypercalcemic activity |
03/12/2002 | US6355630 Estra-1,3,5(10)-triene-7α-thioethers |
03/06/2002 | CN1080267C Preparation of intermediat of 19, 11 beta-bridge steroid |
03/05/2002 | US6352980 Estrenes for inducting hypothalamic effects |
02/28/2002 | WO2002016394A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds |
02/28/2002 | WO2002016393A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
02/28/2002 | WO2002016392A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
02/14/2002 | WO2002012266A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
02/14/2002 | WO2002012265A1 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT |
02/14/2002 | US20020019522 Steroids |
02/14/2002 | US20020019378 Compounds |
02/14/2002 | CA2634715A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy}-11.beta.-hydroxy-16.alpha-methyl-3-oxo-androsta-1,4-diene-17.beta.carbothioic acids-fluoromethyl ester as an anti-inflammatory agent |
02/14/2002 | CA2417826A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
02/07/2002 | WO2002009683A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
02/07/2002 | US20020016455 Epoxidation of cyclopenta(a)phenanthrene derivatives |
02/07/2002 | CA2416152A1 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
02/06/2002 | EP1177206A1 3alpha-hydroxy-3beta methoxymethyl-21-heterocycle substituted steroids with anaesthetic activity |
01/31/2002 | WO2002008243A1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
01/31/2002 | CA2406963A1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
01/23/2002 | EP1173430A1 Enantiomers of mercapto lactones and processes for their synthesis |
01/23/2002 | EP0902789B1 Androstene derivatives |
01/09/2002 | EP1170299A2 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
01/09/2002 | EP1169336A1 Ent-steroids as selectively active estrogens |
01/03/2002 | US20020002155 Glucocorticoids; antiimflammatory and immunosuppressive agents |
01/02/2002 | EP1167381A2 Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and Intermediates useful therein |
01/02/2002 | EP1167380A2 11.alpha.-hydroxy-steroid-4,6-dien-3-one compounds and a process for their preparation |
01/01/2002 | US6335441 5β-cyano-substituted steroid compounds |
12/19/2001 | EP1163258A1 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis |
12/18/2001 | US6331622 Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein |
12/05/2001 | EP0749437B1 Pharmaceutical uses of steroid derivatives |
12/04/2001 | US6326503 Antitumor agents |
11/28/2001 | EP0906332B1 7alpha-(5-methylaminopentyl)-estratrienes, process for the preparation thereof, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl)-estratrienes and use thereof for production of drugs |
11/27/2001 | CA2025294C Bile acid derivatives, processes for their preparation, and use as pharmaceuticals |
11/15/2001 | WO2001085944A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
11/15/2001 | CA2407886A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
10/30/2001 | US6310225 Useful as intermediates for producing vitamin d derivates |
10/25/2001 | WO2001079255A1 A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group |
10/24/2001 | EP1148061A2 Process for preparation of 9, 11- epoxy steroids and intermediates useful therein |
10/17/2001 | EP1144431A2 16-hydroxyestratrienes as selective estrogens |
10/11/2001 | WO2001074840A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents |
10/10/2001 | EP1140972A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
09/20/2001 | WO2001068669A1 6-oxygenated steroidal estrogens with aromatic a and b rings |
09/19/2001 | EP0728140B1 New steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances |
09/13/2001 | WO2001066562A1 Steroid derivatives and process for producing the same |
09/11/2001 | US6288051 Estrogen-dependent breast cancer treatment |
09/07/2001 | WO2001014406A8 Antiandrogen agents |
09/07/2001 | WO2000047603A9 16-hydroxyestratrienes as selective estrogens |
09/06/2001 | US20010020016 Formulation |
08/30/2001 | WO2001062722A2 Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods |
08/28/2001 | US6281204 19-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositions |
08/21/2001 | US6277838 Methods for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
08/14/2001 | US6274572 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds |
08/02/2001 | WO2001055171A1 Mometasone and its preparation |
08/02/2001 | WO2000047603A3 16-hydroxyestratrienes as selective estrogens |
08/02/2001 | EP1144431A3 16-hydroxyestratrienes as selective estrogens |
07/26/2001 | WO2001052856A2 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
07/26/2001 | DE10100779A1 Formulierung Formulation |
07/17/2001 | US6262283 Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds |
07/10/2001 | WO2001051056A1 Fulvestrant formulation |
07/10/2001 | US6258946 Chemical intermediate for diuretic |
06/07/2001 | WO2001040805A1 Steroid compounds for steroid receptor binding assays |
05/16/2001 | EP1099706A2 Estrane sulphamate derivatives as steroid sulphatase inhibitors |
03/27/2001 | USRE37116 Nitrosated and nitrosylated compounds, and compositions and their use for treating respiratory disorders |
03/15/2001 | WO2000066614A8 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY |
03/07/2001 | EP1081157A1 Processes for the preparation of steroid derivatives, intermediates therefor and processes for the preparation of the intermediates |
03/07/2001 | CN1286694A Novel 19-norsteroids substd in position 11 'beta', preparation method and intermediates, application as medicines and pharmaceutical compositions contg. them |
03/07/2001 | CN1286693A 11 'beta'-halogen-7 'alpha'-substd estratrienes, method for producing pharmaceutical preparations contg. said 11 'beta'-halogen-7 'alpha'-substd estratrienes and use of same for producing medicaments |
03/06/2001 | US6197762 Nitrosated and nitrosylated steroids compositions, and methods for treating respiratory disorders |
03/06/2001 | US6197761 17β-2-oxo-tetrahydrofuranyl)-carbothioic acid ester, -carboxylic acid ester and -carboxylic acid amide androstane derivatives |
03/01/2001 | WO2001014406A1 Antiandrogen agents |
02/28/2001 | CN1062562C Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds |
02/27/2001 | CA2081205C Steroids which inhibit angiogenesis |
02/22/2001 | WO2000064882A3 Enantiomers of mercapto lactones and processes for their synthesis |
02/06/2001 | US6184398 16-ene-vitamin D derivatives |
01/30/2001 | US6180780 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
01/23/2001 | US6177420 Fertility control agents; side effect reduction |
01/23/2001 | US6177418 Epoxidized and/or hydroxylated prostane derivatives derived from a fusidium coccineum fungus metabolite isolated from metabolite mixture of fusidic acid |
01/16/2001 | CA2140345C Anti-inflammatory compounds for ophthalmic use |
01/02/2001 | US6169082 Salts of 8,9-dehydroestrone sulfate ester |
12/27/2000 | EP0716604A4 Thiol-derivatized nucleosides and oligonucleosides |
12/12/2000 | US6159960 Steroid sulphatase inhibitors |
12/05/2000 | CA2027627C Process for preparing 21-desoxyprednisolone 17-esters |
11/09/2000 | WO2000066614A1 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY |
11/09/2000 | CA2372342A1 3.alpha.-hydroxy-3.beta. methoxymethyl-21-heterocycle substituted steroids with anesthetic activity |
11/07/2000 | US6143736 Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
11/02/2000 | WO2000064882A2 Enantiomers of mercapto lactones and processes for their synthesis |
11/01/2000 | CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition |
10/31/2000 | US6140316 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions |
10/26/2000 | WO2000063228A1 Ent-steroids as selectively active estrogens |
10/26/2000 | CA2371972A1 Ent-steroids as selectively active estrogens |
10/25/2000 | CN1057770C Application of 19,11 beta-bridged sterodal compound in pharmaceutical working |
10/25/2000 | CN1057767C Androstanes with inducing hypothalamic effects |
10/19/2000 | DE19917930A1 Treating estrogen deficiency associated disorders, e.g. menopausal problems, osteoporosis, neoplasia or neurodegenerative disease, using new or known ent-steroids having bone-selective estrogenic activity |
10/11/2000 | EP1042355A1 11beta-halogen-7alpha-substituted estratrienes, method for producing pharmaceutical preparations containing said 11beta-halogen-7alpha-substituted estratrienes and use of the same for producing medicaments |
10/11/2000 | CN1057305C Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceuticals |
10/04/2000 | EP1039912A1 Angiostatic agents and compositions for controlling ocular hypertension |
09/28/2000 | WO2000056759A1 Processes for the preparation of steroid derivatives, intermediates therefor and processes for the preparation of the intermediates |